balance equationreview2024-12-31
Difference 4616000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$60.14M
Fiscal year ended 2026-06-30Operating income
$7.03M
Fiscal year ended 2026-06-30Free cash flow
$14.18M
Fiscal year ended 2026-06-30MESA LABORATORIES INC /CO/ (MLAB) reported revenue of $60.14M and net income of $2.83M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from MESA LABORATORIES INC /CO/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Instruments For Measurement, Display, and Control.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $60.14M | $63.72M | $65.13M | $60.74M | $59.54M | $62.14M | $62.84M | $57.83M | $58.17M | $58.90M |
| Cost of revenue | $21.13M | $21.52M | $23.33M | $23.41M | $22.60M | $23.72M | $23.09M | $22.38M | $20.92M | $22.35M |
| Gross profit | $39.01M | $42.20M | $41.80M | $37.33M | $36.94M | $38.41M | $39.75M | $35.46M | $37.25M | $36.56M |
| Operating income | $7.03M | $2.75M | $7.98M | $4.72M | $3.06M | $1.47M | $5.78M | $3.51M | $5.58M | -$271.28M |
| Net income | $2.83M | -$4.14M | $3.63M | $2.48M | $4.74M | -$7.11M | -$1.68M | $3.43M | $3.39M | -$254.58M |
| Research & development | $4.72M | $5.25M | $5.03M | $5.05M | $4.98M | $5.10M | $5.05M | $4.63M | $4.74M | $5.20M |
| Weighted-average diluted shares | shares 5.76M | Unavailable | shares 5.56M | shares 5.54M | shares 5.55M | Unavailable | shares 5.43M | shares 5.47M | shares 5.42M | Unavailable |
| Pretax income | $4.35M | -$1.59M | $4.60M | $2.00M | $7.01M | $461.00K | -$2.22M | $3.81M | $3.90M | -$275.33M |
| Income tax expense | $1.52M | $2.54M | $966.00K | -$477.00K | $2.27M | $7.58M | -$541.00K | $384.00K | $517.00K | -$20.75M |
| Diluted EPS | $0.49 | Unavailable | $0.65 | $0.45 | $0.85 | Unavailable | $-0.31 | $0.63 | $0.62 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $17.38M | $24.13M | $18.80M | $17.76M | $17.96M | $20.58M | $18.47M | $17.46M | $16.82M | $17.84M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30.70M | $26.93M | $28.98M | $20.42M | $21.28M | $27.32M | $27.32M | $24.34M | $28.47M | $28.21M |
| Total assets | $419.22M | $427.75M | $434.85M | $430.35M | $435.74M | $433.35M | $433.35M | $454.10M | $440.36M | $446.80M |
| Current assets | $102.85M | $106.27M | $105.63M | $97.43M | $98.26M | $102.68M | $102.68M | $107.98M | $106.69M | $109.35M |
| Total liabilities | $230.46M | $241.50M | $248.16M | $251.88M | $263.25M | $273.52M | $273.52M | $292.65M | $289.63M | $301.40M |
| Current liabilities | $57.32M | $61.90M | $54.40M | $48.30M | $149.49M | $163.96M | $163.96M | $153.23M | $54.86M | $44.31M |
| Total equity incl. NCI | $188.76M | $186.24M | $186.69M | $178.47M | $172.50M | $159.83M | $155.21M | $161.45M | $150.73M | $145.39M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $27.23M | $26.37M | $26.56M | $27.74M | $28.11M | $25.36M | $25.36M | $29.74M | $31.77M | $32.68M |
| Accounts receivable | $34.41M | $44.10M | $40.23M | $40.09M | $39.07M | $41.97M | $41.97M | $40.23M | $35.57M | $39.06M |
| Goodwill | $186.04M | $186.86M | $189.30M | $188.49M | $188.05M | $181.76M | $181.76M | $183.75M | $179.72M | $180.10M |
| Long-term debt | $66.09M | $67.50M | $68.44M | $69.38M | $70.31M | $71.25M | $72.19M | $73.12M | $74.06M | Unavailable |
| Accounts payable | $7.46M | $4.93M | $5.25M | $5.09M | $6.27M | $5.75M | $5.75M | $5.99M | $5.66M | $6.04M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $14.74M | $13.96M | $18.75M | $8.22M | $1.89M | $12.66M | $18.13M | $5.27M | $10.74M | $12.88M |
| Capital expenditures | $559.00K | $417.00K | $732.00K | $1.09M | $1.01M | $757.00K | $813.00K | $1.79M | $891.00K | $535.00K |
| Investing cash flow | -$559.00K | -$417.00K | -$732.00K | -$1.09M | -$1.01M | -$1.01M | -$813.00K | -$1.79M | -$891.00K | $426.00K |
| Financing cash flow | -$10.50M | -$15.76M | -$9.78M | -$7.88M | -$8.43M | -$16.19M | -$10.29M | -$8.61M | -$9.42M | -$12.93M |
| Net change in cash | $3.77M | -$2.05M | $8.55M | -$857.00K | -$6.04M | -$3.64M | $6.62M | -$4.14M | $258.00K | -$10.00K |
| Stock-based compensation | $2.36M | $6.79M | $3.38M | $3.81M | $3.88M | $3.14M | $3.24M | $3.84M | $2.93M | $2.79M |
| Common dividends paid | $884.00K | $884.00K | $884.00K | $882.00K | $873.00K | $870.00K | $869.00K | $866.00K | $863.00K | $864.00K |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $14.18M | $13.54M | $18.02M | $7.13M | $884.00K | $11.91M | $17.32M | $3.48M | $9.85M | $12.35M |
| Gross margin | 64.9% | 66.2% | 64.2% | 61.5% | 62.0% | 61.8% | 63.3% | 61.3% | 64.0% | 62.1% |
| Operating margin | 11.7% | 4.3% | 12.2% | 7.8% | 5.1% | 2.4% | 9.2% | 6.1% | 9.6% | -460.6% |
| FCF margin | 23.6% | 21.3% | 27.7% | 11.7% | 1.5% | 19.2% | 27.6% | 6.0% | 16.9% | 21.0% |
| SBC / revenue | 3.9% | 10.7% | 5.2% | 6.3% | 6.5% | 5.1% | 5.2% | 6.6% | 5.0% | 4.7% |
| Current ratio | 1.79x | 1.72x | 1.94x | 2.02x | 0.66x | 0.63x | 0.63x | 0.70x | 1.94x | 2.47x |
| Revenue YoY growth | 1.0% | 2.6% | 3.6% | 5.0% | 2.4% | 5.5% | 17.5% | 8.8% | 14.9% | 6.0% |
| Net margin | 4.7% | -6.5% | 5.6% | Unavailable | 8.0% | -11.4% | -2.7% | Unavailable | Unavailable | -432.2% |
| R&D / revenue | 7.9% | 8.2% | 7.7% | 8.3% | 8.4% | 8.2% | 8.0% | 8.0% | 8.1% | 8.8% |
| CapEx / revenue | 0.9% | 0.7% | 1.1% | 1.8% | 1.7% | 1.2% | 1.3% | 3.1% | 1.5% | 0.9% |
| Long-term debt / equity | 0.35x | Unavailable | 0.37x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 35.0% | Unavailable | 21.0% | -23.9% | 32.4% | 1643.2% | Unavailable | 10.1% | 13.2% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MLAB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-K · Filed 2026-06-03View SEC filing
10-Q · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-K · Filed 2025-05-28View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.